Request a Program

Leave this field empty

Gastroenterology and Hepatology Advanced Practice Provider (GHAPP) Lunch and Learn Series

In September 2017, the GiHF partnered with the Chronic Liver Disease Foundation (CLDF) to launch the Gastroenterology and Hepatology Advanced Practice Provider (GHAPP) Community Educator Network including more than 90 NPs and PAs from leading academic centers in gastroenterology and hepatology. The GHAPP Community Educator network is a NP/PA-led working group dedicated to educating allied health care professionals on emerging developments in the management of GI disorders and chronic liver disease. The program will feature an in-clinic small group meeting targeting the practice NPs, PAs, nurses, medical assistants and allied health care professionals.

What disease state update would you like to learn about


Preferred Speaker(pick two)

Preferred Date(pick two)

Preferred Format(pick one)


PERSONAL INFORMATION

Name

Address

City

State

Zip

Email

Phone

Fax

Request a Program

Thank you!

A representative will contact you shortly.

LIVE MEETINGS
  • Please select a series
  • IDA
  • GUT

CME Information

Goal Statement

The primary goal of this educational activity is to encourage the application of the latest advances in evidence-based medicine to improve the quality of care and improve outcomes for the patients affected by anemia and GI disease.

Target Audience

This activity is designed for gastroenterologists, nurse practitioners (NPs), physician assistants (PAs) and nurses.

Educational Objectives

Upon completion of this activity, participants should be better able to:


Describe the prevalence of IDA in patients with IBD

Identify patients with IDA

Describe the pathophysiologic processes that underlie IDA in patients with IBD

Differentiate among various oral and IV iron formulations and incorporate them effectively into clinical practice


Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the GI Health Foundation. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc., all other staff at the Annenberg Center for Health Sciences at Eisenhower and the GI Health Foundation have no relationships to disclose.

Learner Assurance Statement

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.


This activity is supported by an educational grant from AMAG Pharmaceutical, Inc.

Provided by

Accredited by

Americans with Disabilities Act

The event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact us prior to the event at 877-782-4532.

  • Speakers
  • Date
  • Location
  • Francis Farraye, MD
  • Thursday
    01/10/2019
  • Boston, MA
  • register >
  • Bincy Abraham, MD
  • Thursday
    01/17/2019
  • Houston, TX
  • register >
  • Maria Abreu, MD
  • Tuesday
    02/12/2019
  • Miami, FL
  • register >

CME Information

Target Audience

Gastroenterologists, internists, family practitioners, physician assistants, physicians-in-training and researchers with an interest in the pathophysiology, diagnosis, and clinical management of gastrointestinal and other common diseases and their relationship to the microbiome.

Educational Objectives

After completing this activity, participants should be better able to:

Discuss evolving concepts regarding the role of the gut microbiome in gastrointestinal and liver health.

Describe current research advances in understanding the composition and function of the gut microbiome.

Discuss how modification of the gut microbiome can be used as a therapeutic strategy in gastrointestinal and liver health.


Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Cincinnati and the Gastrointestinal Health Foundation (GIHF). The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

All faculty and staff involved in the planning or presentation of continuing education activities provided by the University of Cincinnati are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

All additional planning committee members, Gastrointestinal Health Foundation staff, and the University of Cincinnati staff have no relationships to disclose.

Learner Assurance Statement

The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Off-Label Disclosure Statement

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

Americans with Disabilities Act

The event staff will be glad to assist you with any special needs (i.e., physical, dietary). Please contact us prior to the event at 1-973-520-1810.

Provided by

Accredited by

Meetings

  • Speakers
  • Date & Time
  • Location
  • Mark Pimentel, MD, FRCP(C)
    Ian Carrol, MD
    Ruchi Mathur, MD
  • Saturday, January 12, 2019
    7:00 AM
  • The Westin Dallas Downtown
    1201 Main Street
    Dallas, TX
  • register >
  • Nancy Reau, MD
    Christopher Chang, MD
    Mark Riddle, MD
  • Saturday, January 12, 2019
    7:00 AM
  • JW Marriott Chicago
    151 West Adams Street
    Chicago, IL
  • register >
  • Robert Brown, Jr., MD, MPH
    Christopher Chang, MD
    Gary Lichtenstein, MD
  • Saturday, January 26, 2019
    7:00 AM
  • The Westin New York at Times Square
    270 W 43rd Street
    New York, NY
  • register >

© Copyright 2013-2018 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.